In addition, Dr. Jackson has agreed to serve on the Board's newly formed Governance and Nominating Committee; he will be joined on the Committee by current independent directors, Peter Grebow, Ph.D. and Peter Barton Hutt, Esq. Dr. Jackson brings to Q Therapeutics more than 30 years' experience in the life science industry.
http://ift.tt/1ujvjH5
http://ift.tt/1ujvjH5
No comments:
Post a Comment